|
Panomics Incorporated, founded in 2000, develops contextual, quantitative, and systems-level measurement systems that optimize gene, protein, and cellular function research processes. The firm holds multiple patents on its proteomics technology. It provides customers with gene expression, assay, transcriptional regulation, transfection kit, luciferase reporting, stable cell line, ELISA kit, TF-TF interaction array, protein array, cytokine assay, cancer cell isolation kit, and other products. Panomics is known for its QuantiGene gene expression platform, which includes reagent, probe set catalog, and other components. The company also is known for its Procarta TF profiling assays and DeliverX transfection kit product lines. The firm has received several National Institutes of Health (NIH) SBIR development grants, totaling $2.5 million. Panomics was founded by Dr. Jason Li.
|